Pilot phase IV, multicenter, randomized, open-label and controlled study to assess the evolution of peripheral body fat distribution after switching from AZT containing backbone to Truvada in HIV-1-infected patients on HAART (RECOMB Study) To explore changes in limb fat assessed by DEXA measurements, after the substitution of the Zidovudine + Lamivudine NRTI-backbone by Truvada (TDF+FTC) versus maintaining the original Zidovudine-contai...

• Country None
• organs None
• Specialty None

Phase IV, multicenter, randomized, open-label pilot study of Truvada or Emtricitabine alone versus HAART interruption in HIV-infected patients who need to interrupt HAART and who are infected with HIV isolates containing at least 2 TAMs (or K65R) and M184V (GMB Study). Estudio piloto, multicéntrico y aleatorizadode fase IV, de Truvada o emtricitabina solos frente a la suspensión del TARGA en pacientes infectados por el VIH-1 que deciden interrumpir el TARGA y que están infectados por cepas del VIH-1 que contienen como mínimo 2 TAM (o K65R) y M184V (estudio GMB) To compare the immunologic changes with different treatment approaches after HAART discontinuation.

• Country None
• organs None
• Specialty None